Delivery Order SPE2DB20D7059-SPE2DB25FQMF2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,117.08 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price, non-set-aside contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $34.5K delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-unit packages. This non-set-aside, firm fixed-price contract represents a delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a $48,865.86 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is set to be completed by August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award...
- The Defense Logistics Agency awarded a delivery order valued at approximately $75,900 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). The contract is a firm fixed-price delivery order with no set-aside designation, issued on June 20, 2025, with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,361.18 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as...
- The Defense Logistics Agency awarded a delivery order valued at $46,472.02 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by April 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a $74.3K delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with completion scheduled for September 19, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a $36,954.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, which is a non-set-aside competitive award with an ultimate completion date of July 22, 2025, is performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $31,982.02 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQMF2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,948.35 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards covering a wide range of pharmaceutical products, medical supplies, vaccines, and medical devices across multiple therapeutic domains. This award exemplifies AmerisourceBergen's ongoing role as a primary pharmaceutical supplier to the Department of Defense through the DLA's Medical Supply Chain, fulfilling specialized medication requirements for Defense Health Agency customers and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 7/28/25 |